Chargement en cours...
Dasatinib Inhibits Procoagulant and Clot Retracting Activities of Human Platelets
Tyrosine kinase inhibitors (TKI) such as the BCR-ABL inhibitor dasatinib and nilotinib are highly effective therapies for chronic myeloid leukemia (CML). However, several lines of evidence suggest that dasatinib can induce bleeding which may be due to impaired collagen-induced platelet adhesion, agg...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6862041/ https://ncbi.nlm.nih.gov/pubmed/31683623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20215430 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|